April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Ex vivo evaluation of miR-205 as a sensitive biomarker of corneal injury
Author Affiliations & Notes
  • Qinghai Peng
    DSRD, Pfizer, San Diego, CA
  • Walter Collette
    DSRD, Pfizer, San Diego, CA
  • Michelle Twamley
    DSRD, Pfizer, San Diego, CA
  • Wenhu Huang
    DSRD, Pfizer, San Diego, CA
  • Annette John-Baptiste
    DSRD, Pfizer, San Diego, CA
  • Allison Vitsky
    DSRD, Pfizer, San Diego, CA
  • Footnotes
    Commercial Relationships Qinghai Peng, None; Walter Collette, None; Michelle Twamley, None; Wenhu Huang, None; Annette John-Baptiste, None; Allison Vitsky, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 4679. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Qinghai Peng, Walter Collette, Michelle Twamley, Wenhu Huang, Annette John-Baptiste, Allison Vitsky; Ex vivo evaluation of miR-205 as a sensitive biomarker of corneal injury. Invest. Ophthalmol. Vis. Sci. 2014;55(13):4679.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To examine levels of cornea-enriched microRNA-205 in ex vivo corneal culture following exposure to known corneal toxicant Tamoxifen, using lactate dehydrogenase (LDH), a non-specific cytotoxic indicator, as a comparator.

Methods: Corneas were harvested from 6 Long-Evans rats. Each cornea was dissected into 2 equal pieces, then washed and incubated in a 12-well plate with 2mL culture media. Culture media was refreshed ready for drug treatment following initial overnight incubation. Tamoxifen was added to wells at concentrations of 0.2µg, 2 µg and 20µg/ml. 200µl supernatant of culture media was collected at 3 and 24 hours post exposure for extraction of miRNA by Qiagen miRNeasy kit and the miR-205 was assayed via SYBR® Green-based qRT-PCR. Relative copy numbers were obtained utilizing known miR-205 oligos amplified by the same qRT-PCR as the reference. Data are presented as fold change relative to vehicle control ± SEM. LDH was assayed in parallel with these samples utilizing a Siemens Advia 1200.

Results: When corneal explants were exposed to Tamoxifen, miR-205 levels within the culture media demonstrated both dose- and time-dependent increases. Compared to vehicle controls, corneas exposed to 20 µg/mL Tamoxifen demonstrated miR-205 elevations of ~9 fold at 3 hours and ~40 fold at 24 hours. In our model, miR-205 exhibited earlier and greater increases than LDH, which demonstrated ~4 fold elevation compared to vehicle-treated controls at the same dose and timepoint.

Conclusions: This study demonstrated earlier and greater increases of miR-205 levels than LDH post treatment with Tamoxifen in ex vivo culture, indicating that it could be a more sensitive novel biomarker in detecting corneal injury. Although miR-205 needs additional validation as a cornea specific biomarker of injury, these results provide promise for future studies such as in combination with other retinal miRNAs and additional corneal toxicants.

Keywords: 480 cornea: basic science • 481 cornea: endothelium  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×